Alto Neuroscience, Inc. Share Price: ANRO (Alto Neuroscience, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Alto Neuroscience, Inc. share price today?

Accepted Answer

Alto Neuroscience, Inc. (ANRO) share price today is {{live_price}}.

Question 2

Can Indians buy Alto Neuroscience, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Alto Neuroscience, Inc. (ANRO) from India.

With INDmoney, you can buy Alto Neuroscience, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Alto Neuroscience, Inc. at zero transaction cost.

Question 3

How can I buy Alto Neuroscience, Inc. shares from India?

Accepted Answer

It is very easy to buy Alto Neuroscience, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Alto Neuroscience, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Alto Neuroscience, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Alto Neuroscience, Inc. stocks?

Accepted Answer

To start investing in Alto Neuroscience, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Alto Neuroscience, Inc.

Accepted Answer

Today’s highest price of Alto Neuroscience, Inc. (ANRO) is {{1_rba_end}}.

Today’s lowest price of Alto Neuroscience, Inc. (ANRO) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Alto Neuroscience, Inc.

Accepted Answer

Today's market capitalisation of Alto Neuroscience, Inc. ANRO is 333.4M

Question 8

What is the 52 Week High and Low Range of Alto Neuroscience, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Alto Neuroscience, Inc. is down from its 52 Week High?

Accepted Answer

Alto Neuroscience, Inc. (ANRO) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Alto Neuroscience, Inc. is up from its 52 Week low?

Accepted Answer

Alto Neuroscience, Inc. (ANRO) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Alto Neuroscience, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Alto Neuroscience, Inc.

Accepted Answer

Dr. Amit  Etkin M.D., Ph.D. is the current Chief Executive Officer (CEO) of Alto Neuroscience, Inc..

Period	Alto Neuroscience, Inc.	Index (Russel 2000)
3 Months	-2.38%	0.0%
6 Months	-38.7%	0.0%
1 Year	-38.7%	0.0%
3 Years	-38.7%	-20.1%

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	0.0%
Return On Equity TTM	0.0%

Revenue TTM	0.0
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
Diluted Eps TTM	0.0
Quarterly Earnings Growth YOY	0.0

EPS Estimate Current Year	0.0
EPS Estimate Next Year	0.0
EPS Estimate Current Quarter	0.0

Alto Neuroscience, Inc. (ANRO)

Performance

Returns

Highlights

Analyst Recommendation

Technicals Summary

Peers

Company Information

Discover More

FAQs

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Alto Neuroscience, Inc.	-6.96%	-38.7%	-38.7%	-38.7%	-38.7%
Moderna, Inc.	37.56%	83.82%	13.37%	-12.47%	553.14%
Regeneron Pharmaceuticals, Inc.	10.42%	24.29%	32.26%	98.6%	210.52%
Novo Nordisk A/s	7.9%	30.89%	58.53%	230.87%	458.51%
Vertex Pharmaceuticals Incorporated	10.52%	25.13%	30.01%	109.26%	156.43%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Alto Neuroscience, Inc.	NA	NA	NA	0.0	0.0	0.0	NA	NA
Moderna, Inc.	24.73	NA	0.0	-6.46	-0.38	-0.16	NA	33.47
Regeneron Pharmaceuticals, Inc.	29.16	29.16	1.46	44.2	0.15	0.08	NA	250.15
Novo Nordisk A/s	45.83	45.83	2.36	3.5	1.0	0.25	0.01	22.18
Vertex Pharmaceuticals Incorporated	28.9	28.9	0.53	17.11	0.24	0.13	NA	71.8

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Alto Neuroscience, Inc.	NA	$333.4M	-38.7%	NA	0.0%
Moderna, Inc.	Buy	$54.0B	553.14%	24.73	-115.82%
Regeneron Pharmaceuticals, Inc.	Buy	$108.8B	210.52%	29.16	29.45%
Novo Nordisk A/s	Buy	$592.1B	458.51%	45.83	36.55%
Vertex Pharmaceuticals Incorporated	Buy	$115.1B	156.43%	28.9	39.46%

Organization	Alto Neuroscience, Inc.
Employees	0
CEO	Dr. Amit Etkin M.D., Ph.D.
Industry	Miscellaneous